Weisinger Harrison S, Begg Denovan P, Egan Gary F, Jayasooriya Anura P, Lie Fanny, Mathai Michael L, Sinclair Andrew J, Wark John D, Weisinger Richard S
School of Psychological Science, La Trobe University, Victoria 3086, Australia.
Physiol Behav. 2008 Mar 18;93(4-5):820-5. doi: 10.1016/j.physbeh.2007.11.046. Epub 2007 Dec 5.
In vitro studies have demonstrated that angiotensin II (ANG II) induces adipocyte hyperplasia and hypertrophy. The aim of the present study was to determine the effect of angiotensin-converting enzyme inhibition on body weight, adiposity and blood pressure in Sprague-Dawley rats. From birth half of the animals (n=15) were given water to drink, while the remainder were administered perindopril in their drinking water (2 mg/kg/day). Food intake, water intake and body weight were measured weekly. Blood pressure was measured by tail cuff plethysmography at 11-weeks. Body fat content and distribution were assessed using dual energy X-ray absorptiometry and Magnetic Resonance Imaging at 12 weeks. Animals administered with perindopril had a body fat proportion that was half that of controls. This was consistent with, but disproportionately greater than the observed differences in food intake and body weight. Perindopril treatment completely removed hypertension. We conclude that the chronic inhibition of ANG II synthesis from birth specifically reduces the development of adiposity in the rat.
体外研究表明,血管紧张素II(ANG II)可诱导脂肪细胞增生和肥大。本研究的目的是确定血管紧张素转换酶抑制对Sprague-Dawley大鼠体重、肥胖和血压的影响。从出生起,一半的动物(n = 15)给予水饮用,其余动物在饮用水中给予培哚普利(2 mg/kg/天)。每周测量食物摄入量、水摄入量和体重。在11周时通过尾袖体积描记法测量血压。在12周时使用双能X射线吸收法和磁共振成像评估体脂含量和分布。给予培哚普利的动物体脂比例是对照组的一半。这与食物摄入量和体重的观察差异一致,但不成比例地更大。培哚普利治疗完全消除了高血压。我们得出结论,从出生起慢性抑制ANG II合成可特异性降低大鼠肥胖的发生。